@article{f88c21f3afac4557b9e126a08d985e85,
title = "Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study",
abstract = "Introduction: Little is known about missed opportunities (MOs) for HPV vaccination during primary care visits at which influenza vaccination is delivered. Methods: We extracted electronic health records for HPV vaccine-eligible 11-to-17-year-olds. We assessed the proportion of visits during which an influenza vaccine was given and an HPV vaccine was due, but not given (i.e., MOs). Results: Of 56,135 eligible visits, 57.5% represented MOs for HPV vaccination. MOs were more common at visits where an initial versus subsequent HPV vaccine dose was due (68.6% vs. 31.3%) and for acute/chronic and nurse-only visits compared to preventive visits (74.0% and 80.2% vs. 36.7%). In a multivariable model, MOs were more likely for the initial HPV dose and for non-preventive visits, but did not vary by patient sex/age. Conclusions: HPV vaccine MOs were common during visits where influenza vaccine was administered. Increasing simultaneous administration of HPV and influenza vaccines could increase HPV vaccine coverage.",
keywords = "Human papillomavirus vaccine, Influenza vaccine, Missed opportunities, Primary care",
author = "Kelly, {Mary Kate} and Grundmeier, {Robert W.} and Stephens-Shields, {Alisa J.} and Russell Localio and Shone, {Laura P.} and Margaret Wright and Jennifer Steffes and Humiston, {Sharon G.} and Cynthia Rand and Christina Albertin and Abigail Breck and Abney, {Dianna E.} and Greta McFarland and Szilagyi, {Peter G.} and Fiks, {Alexander G.}",
note = "Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Dr. Fiks had an independent research grant from Pfizer. He did not receive salary support, but the grant supported his research team. Dr. Fiks is the co-inventor of the Care Assistant decision and workflow support software. He has earned no income and no licensing agreement exists for the intervention. In the past year, Dr. Humiston has been a consultant to Sanofi Pasteur, which manufactures vaccines, although not HPV vaccine. No other disclosures were reported.]. Funding Information: The authors thank the PROS network primary care pediatricians, nurse practitioners, and physician assistants for their participation in STOP-HPV. The authors also thank Chloe Hannan for her work reviewing and revising the manuscript. Disclosure of author tasks: Ms. Kelly helped conceptualize the study, carried out analyses and interpretations and drafted the initial manuscript. Dr. Grundmeier helped conceptualize the study, coordinated and supervised data acquisition and conducted key data management tasks. Drs. Stephens-Shields and Localio drafted the statistical analysis plan and provided statistical support. Drs. Shone and Wright and Ms. Steffes helped conceptualize the study, coordinate data acquisition, and critically revised the manuscript. Drs. Humiston and Rand helped conceptualize the study and critically revised the manuscript. Ms. Albertin and Ms. Breck coordinated the implementation of the study. Drs. Abney and McFarland advised on the design of the study. Drs. Szilagyi and Fiks conceptualized and designed the study, interpreted the results and made substantial contributions to the manuscript content. All authors reviewed the article for important intellectual content and read and approved the final version of the submitted manuscript. All authors attest they meet the ICMJE criteria for authorship. This work was supported by the National Cancer Institute (NCI) grant number R01CA202261 (PI: Szilagyi, Fiks). Additional infrastructure support was provided by the American Academy of Pediatrics and the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under UA6MC15585 - National Research Network to Improve Children's Health. The information, content, and conclusions presented here are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by AAP, HRSA, HHS, or the U.S. Government. The study sponsors did not have any role in the study design. Funding Information: This work was supported by the National Cancer Institute (NCI) grant number R01CA202261 (PI: Szilagyi, Fiks). Additional infrastructure support was provided by the American Academy of Pediatrics and the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under UA6MC15585 - National Research Network to Improve Children{\textquoteright}s Health. The information, content, and conclusions presented here are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by AAP, HRSA, HHS, or the U.S. Government. The study sponsors did not have any role in the study design. Publisher Copyright: {\textcopyright} 2020 Elsevier Ltd",
year = "2020",
month = jul,
day = "14",
doi = "10.1016/j.vaccine.2020.05.090",
language = "English (US)",
volume = "38",
pages = "5105--5108",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "33",
}